Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body. — Stella
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(8 sites)
United States
Renown Health Medical Oncology, Reno, Nevada
Renown Office of Clinical Research, Reno, Nevada
Renown Regional Medical Center, Reno, Nevada
Japan
Kindai University Hospital- Osaka Medical Campus, Sakai, Osaka
National Hospital Organization Kyushu Cancer Center, Fukuoka
Puerto Rico
Pan American Center for Oncology Trials, LLC, Rio Piedras
Pan American Center for Oncology Trials, LLC, San Juan